| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
GENTS
|
5.00 | 3.8B | 7.01 | 0.91 | 3.60 | 8.3% | 42.4% | 73 | 25 | 9.44 | +64.0% | 83 | 0.14 |
|
YONGA
|
44.70 | 751.0M | 6.19 | 1.24 | — | -18.3% | 38.8% | 64 | 23 | 75.00 | +34.6% | 51 | 0.68 |
|
YATAS
|
30.54 | 4.4B | 24.05 | 0.37 | 3.14 | 5.2% | 19.9% | 62 | 39 | 64.81 | +71.8% | 50 | 0.71 |
|
EUREN
|
3.84 | 8.1B | 18.06 | 0.71 | 6.93 | 3.2% | 37.1% | 55 | 33 | 4.04 | +3.1% | 57 | 0.20 |
|
ORMA
|
154.00 | 4.2B | — | 0.61 | 6.84 | 2.8% | 34.5% | 52 | 33 | 262.04 | +35.8% | 39 | 0.38 |
|
KLSYN
|
15.81 | 6.8B | 18.33 | 2.37 | 8.41 | 8.2% | 44.2% | 42 | 19 | 11.36 | -21.1% | 70 | 0.09 |
|
SUMAS
|
267.00 | 1.6B | 100.00 | 3.40 | 36.32 | 17.2% | 45.5% | 32 | 14 | 76.73 | -53.4% | 87 | 0.07 |
|
DGNMO
|
7.55 | 2.6B | — | 1.77 | 17.69 | -10.7% | 23.2% | 23 | 21 | 3.83 | -25.2% | 6 | 4.62 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.